Two brothers who had prostate cancer surgery within weeks of each other are calling on men with a family history of the ...
MedPage Today on MSN
Similar prostate cancer drugs show different results in real-world study
Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...
Researchers analyze prostate cancer incidence over 20 years in men aged 45-70 years without prostate cancer and identify ...
MedPage Today on MSN
'Most compelling' data yet for metastasis-directed therapy in prostate cancer
But an association with improved overall survival failed to reach statistical significance ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.
Steve, Jim, Andy and Tim Hastings found out they were battling the same disease within 6 months of one another ...
MedPage Today on MSN
Single Midlife PSA Test May Identity Long-Term Prostate Cancer Risk
Many men with low levels could be spared from invasive procedures and frequent testing ...
Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...
Offering prostate cancer tests only to men with a confirmed genetic marker for it leaves black men at greater risk, a man ...
Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...
Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...
The Hastings brothers, from Lancashire in the north west of England, have now been given the all-clear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results